PGP and cancer: In the cancer cells, P-gp expression can be induced by pharmaceutical xenobiotics, such as paclitaxel, rifampicin and tamoxifen, either by the ligand-mediated pathway or through the steroid and xenobiotic receptor SXR [34,35,36,37].